Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02376946 · ClinicalTrials.gov registry record · NA

Third Molar Extraction and Pulsed Electromagnetic FieldTherapy

A NA study, sponsored by Tufts University.

Terminated
Registry status
NA
Development phase
49
Enrollment target

NCT02376946 is a NA study that was terminated before completion, run by Tufts University. The registered enrollment target is 49 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02376946, a NA study, was terminated before completion, sponsored by Tufts University.

TERMINATED
Registry status
NA
Development phase
49 participants
Enrollment target

Study Summary

This study is a prospective, randomized, double-blinded, controlled, clinical trial that evaluates the efficacy of using PEMF in the postoperative period in decreasing swelling and pain after extraction of impacted third molars. The study group will be comprised of subjects that will receive PEMF Actiband treatment for postoperative management of pain and edema. The control group will be comprised of the subjects that will receive a placebo patch as treatment for postoperative management of pain and edema. Thirty (30) subjects will be randomly assigned to each group. Enrollment will continue until 60 qualified subjects have been recruited. Eligibility criteria will be based on the standards for conducting oral surgery procedures on third molar extractions, in addition to safety considerations and contraindications for the Actiband and other agents to be used. Moreover, the selected subjects will have the same surgical difficulty and surgical trauma anticipated standardized by classification system of impacted third molars. All inclusion and exclusion criteria will be thoroughly explained in the relevant section of this proposal. Postoperative edema and pain will be evaluated using 3dMD and Visual Analog Scale, respectively. Different measurements will be obtained immediately before the surgery and in standard periodic intervals as described in the Materials and Methods section of the proposal. Any difference in postoperative edema, pain, and site responsible for request of rescue pain medication will be compared and analyzed between the two groups.

Interventions

  • DEVICE Placebo
  • DEVICE ActiPatch(TM)

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2014-01
Est. Completion 2015-08
Phase NA

Sponsor

Tufts University

163 total trials

What the Registry Record Tells You About NCT02376946

The ClinicalTrials.gov registry entry for NCT02376946 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT02376946 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02376946 about?

NCT02376946 is a clinical study titled "Third Molar Extraction and Pulsed Electromagnetic FieldTherapy". This study is a prospective, randomized, double-blinded, controlled, clinical trial that evaluates the efficacy of using PEMF in the postoperative period in decreasing swelling and pain after extraction of impacted third molars. The study group will be comprised of subjects that will receive PEMF Ac...

What is the current status of trial NCT02376946?

This trial is currently terminated. It is a NA study. The enrollment target is 49 participants. The study started on 2014-01. Estimated completion is 2015-08.

What interventions are being tested in trial NCT02376946?

The interventions under investigation include: Placebo (DEVICE), ActiPatch(TM) (DEVICE).

Who is sponsoring clinical trial NCT02376946?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.